Identifying the status of genetic lesions in cancer clinical trial documents using machine learning

BACKGROUND: Many cancer clinical trials now specify the particular status of a genetic lesion in a patient's tumor in the inclusion or exclusion criteria for trial enrollment. To facilitate search and identification of gene-associated clinical trials by potential participants and clinicians, it...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yonghui, Levy, Mia A, Micheel, Christine M, Yeh, Paul, Tang, Buzhou, Cantrell, Michael J, Cooreman, Stacy M, Xu, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535695/
https://www.ncbi.nlm.nih.gov/pubmed/23282337
http://dx.doi.org/10.1186/1471-2164-13-S8-S21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535695/
https://www.ncbi.nlm.nih.gov/pubmed/23282337
http://dx.doi.org/10.1186/1471-2164-13-S8-S21

Ejemplares similares